6901 Diamond Investment Announces Board Resolution to Invest in Syncell Inc.
NQ Score
87/100
N1 Content Completeness
10
AI Summary (NQ-processed)
Diamond Investment (6901) has announced that its board of directors has resolved to invest in Syncell Inc.'s Series A+ preferred shares, with a maximum investment amount of USD 10.21 million, aimed at long-term strategic growth.
AI Analysis
Frequently Asked Questions
- Q: What does Syncell Inc. do?
- A: Syncell Inc. is a biotech company focused on regenerative medicine and cell therapy R&D.
- Q: How much is Diamond Investment investing?
- A: Up to USD 10.21 million in Syncell Inc.'s Series A+ preferred shares.
- Q: What was the basis for the investment price?
- A: The price was determined based on an auditor's reasonableness opinion and Syncell's fundraising plan.
- Q: Is this a related-party transaction?
- A: No, this is not a related-party transaction and was conducted transparently.
- Q: Is Diamond Investment financially stable?
- A: Yes, it has a working capital of NT$3.69 billion, indicating strong financial health.